Patents by Inventor Gerald Swiss

Gerald Swiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATING AUTOIMMUNE DISEASES WITH GENETICALLY MODIFIED CELLS
    Publication number: 20230149511
    Abstract: Described herein are human genetically modified cells or precursors expressing fugetactic levels of a fugetactic agent, e.g. CXCL12, and methods of treating an autoimmune disease in a subject in need thereof. Also described herein are cells or precursors comprising a transgene or other genetic modification for expression of a nucleic acid sequence encoding a fugetactic agent, e.g. CXCL12.
    Type: Application
    Filed: April 9, 2021
    Publication date: May 18, 2023
    Inventors: Lisa HULLE, David KIEWLICH, Joan ROBBINS, Gerald SWISS
  • METHODS FOR INHIBITING BIOFILM FORMATION
    Publication number: 20210244808
    Abstract: Disclosed are methods and kits of parts useful in inhibiting biofilm formation in vivo in subjects at risk of developing biofilms. These methods include inhibiting biofilm formation where the extracellular matrix in the biofilm includes poly-?-(1?6)glucosamine structures.
    Type: Application
    Filed: November 9, 2020
    Publication date: August 12, 2021
    Inventors: Michael Wyand, John Donnelly, Gerald Swiss